News

Cardiology is undergoing a year of rapid change, driven by innovations that are expanding diagnostic capabilities, advancing treatment options and personalizing care. From artificial intelligence and ...
Harvested marijuana at Goodblend in Austin on Thursday, May 1, 2025. Goodblend, one of three licensed medical marijuana dispensaries in Texas, cultivates the plant and then extracts cannabis oil from ...
Gastric cancer is one of the leading causes of cancer-related mortality worldwide, and peritoneal metastasis, wherein the ...
Neurotech Pharmaceuticals announced the first commercial manufacturing, shipment, and surgical procedure of ENCELTO, the ...
Bayer will partner with Kumquat Biosciences to develop Kumquat’s KRAS G12D inhibitor, which could generate $1.3 billion-plus for the San Diego biotech.
The FDA accepted vepdegestrant’s new drug application for ER+/HER2–, ESR1-mutated advanced breast cancer with a June 5, 2026, ...
Now Offering Veterinary Hemodialysis, Therapeutic Plasma Exchange, and Hemoperfusion ...
The botulinum toxin product CKDB-501A is non-inferior to onabotulinumtoxin A for the treatment of moderate to severe glabellar lines.
If you or someone you love is struggling with mental health or addiction, there’s new hope right here in Central Virginia. Emily chats with the experts at Crede ...